Skip to main content
Clinical Trials/NCT04978090
NCT04978090CompletedNot Applicable

Pilot Study Evaluating the Safety and Efficacy of a Patient-Specific Enteroatmospheric Fistula Isolation and Management Device Independent of Negative Pressure Wound Therapy

Andrew Bernard2 sites in 1 country2 target enrollmentStarted: July 1, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
2
Locations
2
Primary Endpoint
Change in Inpatient Participant Pain Rating

Study Overview

Brief Summary

This study aims to assess the efficacy of a custom fitted device designed to isolate enteroatmospheric fistulas effluent independent of negative pressure wound therapy and to evaluate the effects on the device related to dressing changes, time required for dressing changes, management costs, and the ease of use.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Stable condition, as determined by attending physician
  • Has enteroatmospheric fistula (EAF) in the setting of open abdomen
  • EAF is determined to require surgical resolution

Exclusion Criteria

  • Unstable condition, as determined by attending physician
  • Significant risk of complication

Outcomes

Primary Outcomes

Change in Inpatient Participant Pain Rating

Time Frame: Daily from admission to discharge, up to 1 year

Participants will be asked to rate their pain on a scale of 1-10, where 10 indicates more pain.

Change in Inpatient Participant Mobility Assessment

Time Frame: Daily from admission to discharge, up to 1 year

Mobility will be assessed by asking the participant to select the following statement that most accurately describes their mobility: a. completely immobile; b. unable to sit up supported for less than 10 minutes; c. able to sit supported for more than 10 minutes; d. able to sit unsupported, can lift arms; e. can stand up and pivot torso; or f. can walk and move with minimal assistance required.

Change in Number of Required Wound Dressing Changes - Outpatient

Time Frame: Daily from discharge until fistula resolves or study ends, up to 1 year

The number of dressing changes will be tracked for outpatients on a daily bases.

Change in Outpatient Participant Pain Rating

Time Frame: Weekly from discharge until fistula resolves or study ends, up to 1 year

Participants will be asked to rate their pain on a scale of 1-10, where 10 indicates more pain.

Change in Number of Required Wound Dressing Changes - Inpatient

Time Frame: Daily from admission to discharge, up to 1 year

The number of dressing changes will be tracked for inpatients on a daily bases.

Change in Perceived Ease of Use - Outpatient

Time Frame: Weekly from discharge until fistula resolves or study ends, up to 1 year

Inpatient participants will be asked four questions about the perceived ease of use of the device. The question uses a 5 point Likert scale ranging from strongly disagree to strongly agree, where strongly agree indicates a higher perceived ease of use.

Change in Average Time of Required Fistula-specific Dressing Changes - Inpatient

Time Frame: Daily from admission to discharge, up to 1 year

The time required to change the wound dressings will be recorded.

Change in Outpatient Participant Mobility Assessment

Time Frame: Weekly from until fistula resolves or study ends, up to 1 year

Mobility will be assessed by asking the participant to select the following statement that most accurately describes their mobility: a. completely immobile; b. unable to sit up supported for less than 10 minutes; c. able to sit supported for more than 10 minutes; d. able to sit unsupported, can lift arms; e. can stand up and pivot torso; or f. Can walk and move with minimal assistance required.

Change in Perceived Usefulness - Outpatient

Time Frame: Weekly from discharge until fistula resolves or study ends, up to 1 year

Outpatient participants will be asked two questions about the perceived usefulness of the device. The questions use a 5-point Likert scale ranging from strongly disagree to strongly agree, where strongly agree indicates a higher perceived usefulness.

Change in Perceived Usefulness - Inpatient

Time Frame: Daily from admission to discharge, up to 1 year

Inpatient participants will be asked three questions about the perceived usefulness of the device. The questions use a 5-point Likert scale ranging from strongly disagree to strongly agree, where strongly agree indicates a higher perceived usefulness.

Change in Perceived Ease of Use - Inpatient

Time Frame: Daily from admission to discharge, up to 1 year

Inpatient participants will be asked four questions about the perceived ease of use of the device. The question uses a 5 point Likert scale ranging from strongly disagree to strongly agree, where strongly agree indicates a higher perceived ease of use.

Secondary Outcomes

  • Infection Rates(Through duration of study, up to 1 year)
  • Number of Observed Leakages(Through duration of study, up to 1 year)
  • Length of Stay(Through duration of study, up to 1 year)
  • Fistula Resolution Time(Through duration of study, up to 1 year)
  • Complication Occurrences(Through duration of study, up to 1 year)

Investigators

Sponsor
Andrew Bernard
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Andrew Bernard

Professor

University of Kentucky

Study Sites (2)

Loading locations...

Similar Trials